Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Remnant lipoproteins

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Polygenic risk scores: how much do they add?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Impact of metabolic dysfunction on cognition in humans

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Apolipoprotein M/sphingosine-1-phosphate: novel effects on lipids, inflammation and kidney biology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Relation between plasma and brain lipids

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. HIV infection is associated with type 2 diabetes mellitus

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE OF REVIEW: To review recent advances in the field of remnant lipoproteins and remnant cholesterol with a focus on cardiovascular disease risk.

RECENT FINDINGS: In line with previous years' research, current observational, genetic, and mechanistic studies find remnant lipoproteins (defined in different ways) to be involved in atherosclerosis development and cardiovascular disease risk. High concentrations of remnant cholesterol could explain some of the residual risk of cardiovascular disease seen after LDL cholesterol lowering. This will be increasingly important as populations worldwide become more obese and more have diabetes, both of which elevate remnant cholesterol concentrations. Many smaller scale studies and post hoc analyses show that remnant cholesterol can be lowered by different types of drugs; however, results from large scale studies with the primary aim of reducing cardiovascular disease risk through lowering of remnant cholesterol in individuals with elevated concentrations are still missing, although some are under way.

SUMMARY: Remnant cholesterol is a risk factor for cardiovascular disease, and can be lowered by different types of drugs; however, large scale studies of cardiovascular disease risk reduction through remnant lipoprotein lowering are under way.

OriginalsprogEngelsk
TidsskriftCurrent Opinion in Lipidology
Vol/bind28
Udgave nummer4
Sider (fra-til)300-307
Antal sider8
ISSN0957-9672
DOI
StatusUdgivet - aug. 2017

ID: 52336335